Long-acting β₂ agonists

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 99-104

Informa Healthcare

Access to resources Recommend Favorite

Inhaled corticosteroids plus long-acting &bgr;₂-agonists as a combined therapy in asthma

By García-Marcos Luis   Schuster Antje   Barroso Nicolás Cobos  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 1, 2003-01 ,pp. : 23-39

Informa Healthcare

Access to resources Recommend Favorite

Advances in Asthma and COPD Treatment: Combination Therapy with Inhaled Corticosteroids and Long-Acting &bgr;2-Agonists.

By  

Current Pharmaceutical Design, Vol. 12, Iss. 25, 2006-01 ,pp. : 3261-3279

Bentham Science Publishers

Access to resources Recommend Favorite

New long-acting β₂-agonists

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 9, 2004-09 ,pp. : 1385-1388

Informa Healthcare

Access to resources Recommend Favorite

Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting &bgr;₂-agonists: results of the pacman cohort

By Zuurhout Miranda JL   Vijverberg Susanne JH   Raaijmakers Jan AM   Koenderman Leo   Postma Dirkje S   Koppelman Gerard H   Maitland-van der Zee Anke Hilse  

Pharmacogenomics, Vol. 14, Iss. 16, 2013-12 ,pp. : 1965-1971

Future Medicine

Access to resources Recommend Favorite